This Week in Nature

In this week's Nature Biotechnology, a team from Massachusetts General Hospital reports on the development of a next-generation CRISPR-based gene-editing platform. Monomeric Cas9 nucleases are commonly used to induce the genomic alterations in CRISPR systems, but the researchers note that these often result in unwanted off-target mutations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.